217 related articles for article (PubMed ID: 3022879)
1. Effects of serotonin, cyproheptadine and reserpine on corticotropin-releasing factor release from the rat hypothalamus in vitro.
Nakagami Y; Suda T; Yajima F; Ushiyama T; Tomori N; Sumitomo T; Demura H; Shizume K
Brain Res; 1986 Oct; 386(1-2):232-6. PubMed ID: 3022879
[TBL] [Abstract][Full Text] [Related]
2. The effect of cyproheptadine on the release of corticotrophin releasing factor.
Jones MT; Birmingham M; Gillham B; Holmes M; Smith T
Clin Endocrinol (Oxf); 1979 Feb; 10(2):203-5. PubMed ID: 311717
[TBL] [Abstract][Full Text] [Related]
3. Effects of cyproheptadine, reserpine, and synthetic corticotropin-releasing factor on pituitary glands from patients with Cushing's disease.
Suda T; Tozawa F; Mouri T; Sasaki A; Shibasaki T; Demura H; Shizume K
J Clin Endocrinol Metab; 1983 Jun; 56(6):1094-9. PubMed ID: 6302123
[TBL] [Abstract][Full Text] [Related]
4. Time course study on the effect of reserpine on hypothalamic immunoreactive CRF levels in rats.
Suda T; Tomori N; Yajima F; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
Brain Res; 1987 Mar; 405(2):247-52. PubMed ID: 3032352
[TBL] [Abstract][Full Text] [Related]
5. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro.
Tsagarakis S; Navarra P; Rees LH; Besser M; Grossman A; Navara P
Endocrinology; 1989 May; 124(5):2330-5. PubMed ID: 2539975
[TBL] [Abstract][Full Text] [Related]
6. Lack of effect of serotonin and norepinephrine on CRF release from hypothalami in vitro.
Tate PW; Newell DC; Cook EE; Martinson DR; Hagen TC
Horm Metab Res; 1983 Jul; 15(7):342-6. PubMed ID: 6309639
[TBL] [Abstract][Full Text] [Related]
7. In vitro study of immunoreactive corticotropin-releasing factor release from the rat hypothalamus.
Suda T; Yajima F; Tomori N; Demura H; Shizume K
Life Sci; 1985 Oct; 37(16):1499-505. PubMed ID: 2995748
[TBL] [Abstract][Full Text] [Related]
8. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
[TBL] [Abstract][Full Text] [Related]
9. Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro.
Hillhouse EW; Milton NG
J Endocrinol; 1989 Sep; 122(3):713-8. PubMed ID: 2572662
[TBL] [Abstract][Full Text] [Related]
10. Cyproheptadine and desmethylcyproheptadine directly inhibit the release of adrenocorticotrophin and beta-lipotrophin/beta-endorphin activity from the neurointermediate lobe of the rat pituitary gland.
Lamberts SW; Bons EG; Uitterlinden P; Hackeng WH
J Endocrinol; 1983 Mar; 96(3):395-400. PubMed ID: 6300274
[TBL] [Abstract][Full Text] [Related]
11. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism.
Cambronero JC; Rivas FJ; Borrell J; Guaza C
Eur J Pharmacol; 1992 Aug; 219(1):75-80. PubMed ID: 1327836
[TBL] [Abstract][Full Text] [Related]
12. Characterization of PGE2 inhibition of corticotropin releasing factor-mediated ACTH release.
Sobel DO
Brain Res; 1987 May; 411(1):102-7. PubMed ID: 3038258
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of corticotrophin releasing factor secretion in the pentobarbitone-morphine-treated rat.
Buckingham JC
Eur J Pharmacol; 1984 Feb; 98(2):211-21. PubMed ID: 6325216
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of corticosteroid inhibition of adrenocorticotrophin release from the anterior pituitary gland of the rat.
Mahmoud SN; Scaccianoce S; Scraggs PR; Nicholson SA; Gillham B; Jones MT
J Endocrinol; 1984 Jul; 102(1):33-42. PubMed ID: 6330266
[TBL] [Abstract][Full Text] [Related]
15. ACTH release in pituitary cell cultures. Effect of neurogenic peptides and neurotransmitter substances on ACTH release induced by hypothalamic corticotropin releasing factor (CRF).
Hashimoto K; Yunoki S; Takahara J; Ofuji T
Endocrinol Jpn; 1979 Feb; 26(1):103-9. PubMed ID: 35343
[TBL] [Abstract][Full Text] [Related]
16. Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor.
Wynn PC; Aguilera G; Morell J; Catt KJ
Biochem Biophys Res Commun; 1983 Jan; 110(2):602-8. PubMed ID: 6301458
[TBL] [Abstract][Full Text] [Related]
17. [Prostaglandin D2-endogenous regulator of physiological sleep-inhibited CRF-induced ACTH secretion from rat anterior pituitary cells].
Kudo M; Kudo T; Matsuki A
Nihon Naibunpi Gakkai Zasshi; 1990 Nov; 66(11):1158-63. PubMed ID: 1962750
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated actions of corticotropin-releasing factor in pituitary gland and nervous system.
Aguilera G; Wynn PC; Harwood JP; Hauger RL; Millan MA; Grewe C; Catt KJ
Neuroendocrinology; 1986; 43(1):79-88. PubMed ID: 3012395
[TBL] [Abstract][Full Text] [Related]
19. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro.
Gillies G; Puri A; Hodgkinson S; Lowry PJ
J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effect of acetylcholine on immunoreactive corticotropin-releasing factor release from the rat hypothalamus in vitro.
Suda T; Yajima F; Tomori N; Sumitomo T; Nakagami Y; Ushiyama T; Demura H; Shizume K
Life Sci; 1987 Feb; 40(7):673-7. PubMed ID: 3492648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
